EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. § 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q of Novelos Therapeutics,
Inc.,
(the “Company”) for the quarter ended March 31, 2008, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), we, Harry
S. Palmin, President and Chief Executive Officer of the Company, and Joanne
M.
Protano, Vice President, Chief Financial Officer and Treasurer of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to our knowledge, that:
1)
The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2)
The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
Harry
S. Palmin
|
President,
Chief Executive Officer (Principal Executive Officer)
|
|
Date:
May 14, 2008
|
|
/s/
Joanne M. Protano
|
|
Chief
Financial Officer (Principal Financial and Accounting
Officer)
|
Date:
May
14, 2008